|Day's Range||36.20 - 37.05|
These titans of big pharma just enrolled patients into phase 3 clinical trials for this promising blood thinner.
Many dividend stocks have fallen out of favor over the past year as rising interest rates made certificates of deposit, bonds, and T-bills more attractive options for income investors. Many dividend investors love Coca-Cola for three reasons: It runs an evergreen business; it's a Dividend King, having raised its payout annually for 61 consecutive years, and it pays an attractive forward dividend yield of about 3.1%.
In the latest trading session, Johnson & Johnson (JNJ) closed at $153.30, marking a +0.43% move from the previous day.